Mylan Pharmaceuticals Inc. Insulin Glargine Injection Pens - recalled due to Potential missing label, USA
2 years ago •source fda.gov • details
Recall notice
Updated:
2 years ago •source fda.gov • details
Recall notice
3 years ago •source fda.gov • details
Recall notice
3 years ago •source fda.gov • details
Recall notice
3 years ago •source fda.gov • details
Recall notice
3 years ago •source fda.gov • details
Recall notice
3 years ago •source fda.gov • details
Recall notice
3 years ago • details
Regulatory Report
4 years ago • details
Regulatory Report
4 years ago • details
Regulatory Report
Search